Conduct of trials in private clinical practice

被引:6
|
作者
Beran, RG [1 ]
Beran, ME [1 ]
机构
[1] Epilepsy Res & Serv, Chatswood, NSW 2067, Australia
关键词
private practice; trials; new drugs; epilepsy research; patients;
D O I
10.1111/j.1528-1157.2000.tb00256.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: Trials of antiepileptic medications are usually based in tertiary referral centers with teaching hospital resources. Epilepsy Research & Services (ERS) is part of a private outpatient neurological clinic that is involved in research as part of multicenter clinical trials, adhering to Good Clinical Research Practice. ERS is subject to external monitoring and auditing, but does so outside of the teaching hospital environment. Methods: The clinic is operated by a neurologist supported by a research assistant, administrative and nursing staff and has no formal university attachment. Patients are recruited for trials from routine referrals for clinical care. The center has formal ties with the ethics committee of the local teaching hospital, but none of the team is formally attached to that hospital. Results: The center conducted trials of zonisamide, oxcarbazepine, gabapentin, remacemide, tiagabine, vigabatrin, felbamate, and lamotrigine both as add-on trials in refractory seizure disorders and as monotherapy trials in de novo epilepsy. More than 200 patients have been recruited for trials at ERS (with some patients being involved in more than one trial). External review endorsed ERS as a superior environment for such research and as a model for other centers. Conclusions: Private practice is a viable alternative for the conduct of clincial trials and should be considered when establishing such protocols. Simplicity of administration and clinical practice, which more closely mirrors standard patient care, may enhance recruitment and management.
引用
下载
收藏
页码:875 / 879
页数:5
相关论文
共 50 条
  • [31] Optimizing a team approach for successful accrual to and conduct of clinical trials in a community oncology practice.
    Braun-Inglis, Christa M.
    Agonoy, Janela
    Fukui, Jami Aya
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [32] Update in methodology and conduct of cancer clinical trials
    Therasse, P.
    Eisenhauer, E. A.
    Buyse, M.
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (10) : 1322 - 1330
  • [33] DESIGN AND CONDUCT OF CLINICAL TRIALS IN MYOCARDIAL INFARCTION
    REID, DD
    CIRCULATION, 1969, 40 (5S4) : IV91 - &
  • [34] CONDUCT OF COOPERATIVE FIELD AND CLINICAL-TRIALS
    GREENBERG, BG
    AMERICAN STATISTICIAN, 1959, 13 (03): : 13 - &
  • [35] Deficiencies in the conduct and reporting of pediatric clinical trials
    Moore, Barbara J.
    Popko, Stacey H.
    Tao, Laurent S.
    JOURNAL OF PEDIATRICS, 2018, 198 : 326 - 326
  • [36] GUIDELINES FOR SUBMISSIONS TO CONDUCT CLINICAL TRIALS WITH RADIOPHARMACEUTICALS
    ARORA, HRK
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1975, 5 (02): : 178 - 178
  • [37] Regulatory developments in the conduct of clinical trials in India
    Chaudhury, R. Roy
    Mehta, D.
    GLOBAL HEALTH EPIDEMIOLOGY AND GENOMICS, 2016, 1
  • [38] How to Conduct Clinical Trials in Children: A Tutorial
    Shakhnovich, Valentina
    Hornik, Christoph P.
    Kearns, Gregory L.
    Weigel, Jaylene
    Abdel-Rahman, Susan M.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, 12 (03): : 218 - 230
  • [39] THE CONDUCT AND PRINCIPLES OF RANDOMIZED CLINICAL-TRIALS
    KLIMT, CR
    CONTROLLED CLINICAL TRIALS, 1981, 1 (04): : 283 - 293
  • [40] Improving the conduct and reporting of clinical trials - Reply
    Johansen, HK
    Gotzsche, PC
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (21): : 2789 - 2790